nodes	percent_of_prediction	percent_of_DWPC	metapath
Sparfloxacin—TOP2A—breast cancer	0.263	0.779	CbGaD
Sparfloxacin—TOP2A—Idarubicin—breast cancer	0.12	0.274	CbGbCtD
Sparfloxacin—ABCB1—breast cancer	0.0747	0.221	CbGaD
Sparfloxacin—TOP2A—Mitoxantrone—breast cancer	0.0517	0.118	CbGbCtD
Sparfloxacin—TOP2A—Epirubicin—breast cancer	0.0419	0.0952	CbGbCtD
Sparfloxacin—TOP2A—Doxorubicin—breast cancer	0.0222	0.0506	CbGbCtD
Sparfloxacin—ABCC2—Tamoxifen—breast cancer	0.0218	0.0495	CbGbCtD
Sparfloxacin—ABCB1—Toremifene—breast cancer	0.0194	0.0442	CbGbCtD
Sparfloxacin—ABCC2—Paclitaxel—breast cancer	0.0169	0.0385	CbGbCtD
Sparfloxacin—ABCC2—Irinotecan—breast cancer	0.0167	0.038	CbGbCtD
Sparfloxacin—ABCC2—Carboplatin—breast cancer	0.0159	0.0363	CbGbCtD
Sparfloxacin—ABCC2—Vinblastine—breast cancer	0.0149	0.0338	CbGbCtD
Sparfloxacin—ABCB1—Lapatinib—breast cancer	0.0142	0.0322	CbGbCtD
Sparfloxacin—ABCC2—Docetaxel—breast cancer	0.0122	0.0278	CbGbCtD
Sparfloxacin—ABCC2—Doxorubicin—breast cancer	0.00913	0.0208	CbGbCtD
Sparfloxacin—ABCC2—Methotrexate—breast cancer	0.00884	0.0201	CbGbCtD
Sparfloxacin—ABCB1—Vinorelbine—breast cancer	0.00786	0.0179	CbGbCtD
Sparfloxacin—ABCB1—Tamoxifen—breast cancer	0.00709	0.0161	CbGbCtD
Sparfloxacin—ABCB1—Mitoxantrone—breast cancer	0.00692	0.0157	CbGbCtD
Sparfloxacin—ABCB1—Gemcitabine—breast cancer	0.00611	0.0139	CbGbCtD
Sparfloxacin—ABCB1—Paclitaxel—breast cancer	0.00552	0.0126	CbGbCtD
Sparfloxacin—ABCB1—Irinotecan—breast cancer	0.00545	0.0124	CbGbCtD
Sparfloxacin—ABCB1—Vinblastine—breast cancer	0.00484	0.011	CbGbCtD
Sparfloxacin—ABCB1—Docetaxel—breast cancer	0.00399	0.00908	CbGbCtD
Sparfloxacin—ABCB1—Doxorubicin—breast cancer	0.00298	0.00677	CbGbCtD
Sparfloxacin—ABCB1—Methotrexate—breast cancer	0.00288	0.00656	CbGbCtD
Sparfloxacin—TOP2A—nipple—breast cancer	0.00103	0.0955	CbGeAlD
Sparfloxacin—Moxifloxacin—TOP2A—breast cancer	0.000695	0.236	CrCbGaD
Sparfloxacin—SLC22A5—mammary gland—breast cancer	0.000662	0.0612	CbGeAlD
Sparfloxacin—TOP2A—endometrium—breast cancer	0.000624	0.0577	CbGeAlD
Sparfloxacin—TOP2A—uterus—breast cancer	0.000575	0.0531	CbGeAlD
Sparfloxacin—TOP2A—adipose tissue—breast cancer	0.000563	0.052	CbGeAlD
Sparfloxacin—SLC22A5—nipple—breast cancer	0.000548	0.0506	CbGeAlD
Sparfloxacin—TOP2A—adrenal gland—breast cancer	0.000505	0.0466	CbGeAlD
Sparfloxacin—TOP2A—bone marrow—breast cancer	0.000488	0.0451	CbGeAlD
Sparfloxacin—TOP2A—female gonad—breast cancer	0.000471	0.0435	CbGeAlD
Sparfloxacin—Ofloxacin—ABCC1—breast cancer	0.000398	0.135	CrCbGaD
Sparfloxacin—TOP2A—Docetaxel—Paclitaxel—breast cancer	0.000363	0.121	CbGdCrCtD
Sparfloxacin—Lomefloxacin—TOP2A—breast cancer	0.00036	0.122	CrCbGaD
Sparfloxacin—TOP2A—Gefitinib—Lapatinib—breast cancer	0.000356	0.118	CbGdCrCtD
Sparfloxacin—ABCC2—female reproductive system—breast cancer	0.000354	0.0327	CbGeAlD
Sparfloxacin—SLC22A5—skin of body—breast cancer	0.000351	0.0324	CbGeAlD
Sparfloxacin—ABCC2—adrenal gland—breast cancer	0.000345	0.0319	CbGeAlD
Sparfloxacin—SLC22A5—endometrium—breast cancer	0.000331	0.0305	CbGeAlD
Sparfloxacin—Levofloxacin—TOP2A—breast cancer	0.000307	0.104	CrCbGaD
Sparfloxacin—Ofloxacin—TOP2A—breast cancer	0.000307	0.104	CrCbGaD
Sparfloxacin—TOP2A—lymph node—breast cancer	0.000303	0.0279	CbGeAlD
Sparfloxacin—SLC22A5—pituitary gland—breast cancer	0.000299	0.0276	CbGeAlD
Sparfloxacin—ABCC2—endocrine gland—breast cancer	0.000299	0.0276	CbGeAlD
Sparfloxacin—SLC22A5—adipose tissue—breast cancer	0.000298	0.0275	CbGeAlD
Sparfloxacin—Ciprofloxacin—TOP2A—breast cancer	0.000297	0.101	CrCbGaD
Sparfloxacin—SLC22A5—female reproductive system—breast cancer	0.000274	0.0253	CbGeAlD
Sparfloxacin—SLC22A5—adrenal gland—breast cancer	0.000267	0.0247	CbGeAlD
Sparfloxacin—TOP2A—Topotecan—Irinotecan—breast cancer	0.000258	0.0857	CbGdCrCtD
Sparfloxacin—SLC22A5—female gonad—breast cancer	0.000249	0.023	CbGeAlD
Sparfloxacin—TOP2A—Vindesine—Vinorelbine—breast cancer	0.000231	0.0766	CbGdCrCtD
Sparfloxacin—ABCB1—embryo—breast cancer	0.00021	0.0194	CbGeAlD
Sparfloxacin—ABCC2—lymph node—breast cancer	0.000207	0.0191	CbGeAlD
Sparfloxacin—Gatifloxacin—ALB—breast cancer	0.000199	0.0678	CrCbGaD
Sparfloxacin—TOP2A—Vindesine—Vinblastine—breast cancer	0.000185	0.0613	CbGdCrCtD
Sparfloxacin—TOP2A—Paclitaxel—Docetaxel—breast cancer	0.000181	0.0602	CbGdCrCtD
Sparfloxacin—ABCB1—epithelium—breast cancer	0.000171	0.0158	CbGeAlD
Sparfloxacin—SLC22A5—lymph node—breast cancer	0.00016	0.0148	CbGeAlD
Sparfloxacin—ABCB1—endometrium—breast cancer	0.000154	0.0142	CbGeAlD
Sparfloxacin—ABCB1—uterus—breast cancer	0.000141	0.0131	CbGeAlD
Sparfloxacin—ABCB1—pituitary gland—breast cancer	0.000139	0.0128	CbGeAlD
Sparfloxacin—ABCB1—adipose tissue—breast cancer	0.000138	0.0128	CbGeAlD
Sparfloxacin—TOP2A—Daunorubicin—Idarubicin—breast cancer	0.000132	0.0439	CbGdCrCtD
Sparfloxacin—TOP2A—Doxorubicin—Idarubicin—breast cancer	0.000132	0.0439	CbGdCrCtD
Sparfloxacin—TOP2A—Epirubicin—Idarubicin—breast cancer	0.000132	0.0439	CbGdCrCtD
Sparfloxacin—ABCB1—female reproductive system—breast cancer	0.000127	0.0117	CbGeAlD
Sparfloxacin—TOP2A—Vincristine—Vinorelbine—breast cancer	0.000125	0.0413	CbGdCrCtD
Sparfloxacin—ABCB1—adrenal gland—breast cancer	0.000124	0.0115	CbGeAlD
Sparfloxacin—ABCB1—bone marrow—breast cancer	0.00012	0.0111	CbGeAlD
Sparfloxacin—TOP2A—Vinorelbine—Vinblastine—breast cancer	0.000117	0.0387	CbGdCrCtD
Sparfloxacin—ABCB1—female gonad—breast cancer	0.000116	0.0107	CbGeAlD
Sparfloxacin—ABCB1—endocrine gland—breast cancer	0.000108	0.00994	CbGeAlD
Sparfloxacin—Levofloxacin—CYP3A4—breast cancer	0.000105	0.0357	CrCbGaD
Sparfloxacin—Ciprofloxacin—CYP3A4—breast cancer	0.000101	0.0345	CrCbGaD
Sparfloxacin—TOP2A—Vinblastine—Vinorelbine—breast cancer	0.0001	0.0333	CbGdCrCtD
Sparfloxacin—TOP2A—Vincristine—Vinblastine—breast cancer	9.96e-05	0.0331	CbGdCrCtD
Sparfloxacin—Levofloxacin—ABCB1—breast cancer	8.74e-05	0.0297	CrCbGaD
Sparfloxacin—Ciprofloxacin—ABCB1—breast cancer	8.44e-05	0.0287	CrCbGaD
Sparfloxacin—TOP2A—Methyltestosterone—Fluoxymesterone—breast cancer	8.39e-05	0.0278	CbGdCrCtD
Sparfloxacin—ABCB1—lymph node—breast cancer	7.44e-05	0.00687	CbGeAlD
Sparfloxacin—TOP2A—Cytarabine—Gemcitabine—breast cancer	6.55e-05	0.0217	CbGdCrCtD
Sparfloxacin—TOP2A—Doxorubicin—Epirubicin—breast cancer	6.07e-05	0.0201	CbGdCrCtD
Sparfloxacin—TOP2A—Daunorubicin—Epirubicin—breast cancer	6.07e-05	0.0201	CbGdCrCtD
Sparfloxacin—TOP2A—Idarubicin—Epirubicin—breast cancer	6.07e-05	0.0201	CbGdCrCtD
Sparfloxacin—TOP2A—Idarubicin—Doxorubicin—breast cancer	5.62e-05	0.0186	CbGdCrCtD
Sparfloxacin—TOP2A—Daunorubicin—Doxorubicin—breast cancer	5.62e-05	0.0186	CbGdCrCtD
Sparfloxacin—TOP2A—Epirubicin—Doxorubicin—breast cancer	5.62e-05	0.0186	CbGdCrCtD
Sparfloxacin—TOP2A—Norethindrone—Fluoxymesterone—breast cancer	5.47e-05	0.0181	CbGdCrCtD
Sparfloxacin—TOP2A—Azacitidine—Gemcitabine—breast cancer	4.7e-05	0.0156	CbGdCrCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—breast cancer	3.04e-05	0.00055	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—breast cancer	3.02e-05	0.000546	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CCNE1—breast cancer	2.98e-05	0.00054	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—breast cancer	2.97e-05	0.000538	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC2A1—breast cancer	2.97e-05	0.000537	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—breast cancer	2.95e-05	0.000533	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—breast cancer	2.94e-05	0.000532	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—TYMS—breast cancer	2.93e-05	0.00053	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—JUN—breast cancer	2.92e-05	0.000528	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—breast cancer	2.9e-05	0.000524	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—COX11—breast cancer	2.89e-05	0.000523	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC39A7—breast cancer	2.89e-05	0.000523	CbGpPWpGaD
Sparfloxacin—SLC22A5—SLC-mediated transmembrane transport—ALB—breast cancer	2.88e-05	0.000522	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—THBS1—breast cancer	2.88e-05	0.000522	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP7—breast cancer	2.88e-05	0.000522	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK8—breast cancer	2.88e-05	0.000521	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—PTEN—breast cancer	2.82e-05	0.000511	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—H2AFX—breast cancer	2.82e-05	0.000511	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SLC2A2—breast cancer	2.8e-05	0.000507	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—E2F1—breast cancer	2.8e-05	0.000507	CbGpPWpGaD
Sparfloxacin—Diarrhoea—Fluorouracil—breast cancer	2.77e-05	0.000184	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Capecitabine—breast cancer	2.77e-05	0.000184	CcSEcCtD
Sparfloxacin—Tinnitus—Methotrexate—breast cancer	2.77e-05	0.000183	CcSEcCtD
Sparfloxacin—Tachycardia—Capecitabine—breast cancer	2.77e-05	0.000183	CcSEcCtD
Sparfloxacin—Hypoaesthesia—Epirubicin—breast cancer	2.76e-05	0.000183	CcSEcCtD
Sparfloxacin—TOP2A—Circadian rythm related genes—MAPK8—breast cancer	2.76e-05	0.0005	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—CASP8—breast cancer	2.76e-05	0.000499	CbGpPWpGaD
Sparfloxacin—Pharyngitis—Epirubicin—breast cancer	2.76e-05	0.000183	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—BRCA2—breast cancer	2.75e-05	0.000498	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—breast cancer	2.75e-05	0.000498	CbGpPWpGaD
Sparfloxacin—Sweating—Doxorubicin—breast cancer	2.75e-05	0.000182	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—ABCG2—breast cancer	2.74e-05	0.000497	CbGpPWpGaD
Sparfloxacin—Urticaria—Paclitaxel—breast cancer	2.74e-05	0.000182	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Capecitabine—breast cancer	2.74e-05	0.000181	CcSEcCtD
Sparfloxacin—Oedema peripheral—Epirubicin—breast cancer	2.74e-05	0.000181	CcSEcCtD
Sparfloxacin—Haematuria—Doxorubicin—breast cancer	2.73e-05	0.000181	CcSEcCtD
Sparfloxacin—Abdominal pain—Paclitaxel—breast cancer	2.73e-05	0.000181	CcSEcCtD
Sparfloxacin—Body temperature increased—Paclitaxel—breast cancer	2.73e-05	0.000181	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—breast cancer	2.73e-05	0.000493	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—NCOA1—breast cancer	2.71e-05	0.000491	CbGpPWpGaD
Sparfloxacin—Epistaxis—Doxorubicin—breast cancer	2.7e-05	0.000179	CcSEcCtD
Sparfloxacin—Anorexia—Capecitabine—breast cancer	2.7e-05	0.000179	CcSEcCtD
Sparfloxacin—Vomiting—Irinotecan—breast cancer	2.69e-05	0.000178	CcSEcCtD
Sparfloxacin—Vomiting—Mitoxantrone—breast cancer	2.69e-05	0.000178	CcSEcCtD
Sparfloxacin—Sinusitis—Doxorubicin—breast cancer	2.69e-05	0.000178	CcSEcCtD
Sparfloxacin—Dizziness—Fluorouracil—breast cancer	2.68e-05	0.000178	CcSEcCtD
Sparfloxacin—Agranulocytosis—Doxorubicin—breast cancer	2.67e-05	0.000177	CcSEcCtD
Sparfloxacin—Rash—Mitoxantrone—breast cancer	2.67e-05	0.000177	CcSEcCtD
Sparfloxacin—Rash—Irinotecan—breast cancer	2.67e-05	0.000177	CcSEcCtD
Sparfloxacin—Dermatitis—Mitoxantrone—breast cancer	2.67e-05	0.000177	CcSEcCtD
Sparfloxacin—Dermatitis—Irinotecan—breast cancer	2.67e-05	0.000177	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Docetaxel—breast cancer	2.67e-05	0.000177	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—CCNE1—breast cancer	2.67e-05	0.000483	CbGpPWpGaD
Sparfloxacin—Chills—Methotrexate—breast cancer	2.66e-05	0.000176	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—breast cancer	2.66e-05	0.000481	CbGpPWpGaD
Sparfloxacin—Headache—Irinotecan—breast cancer	2.65e-05	0.000176	CcSEcCtD
Sparfloxacin—Headache—Mitoxantrone—breast cancer	2.65e-05	0.000176	CcSEcCtD
Sparfloxacin—Insomnia—Docetaxel—breast cancer	2.65e-05	0.000175	CcSEcCtD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—PLG—breast cancer	2.64e-05	0.000479	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC22A18—breast cancer	2.64e-05	0.000478	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—BIRC5—breast cancer	2.63e-05	0.000477	CbGpPWpGaD
Sparfloxacin—Paraesthesia—Docetaxel—breast cancer	2.63e-05	0.000174	CcSEcCtD
Sparfloxacin—Erythema multiforme—Epirubicin—breast cancer	2.63e-05	0.000174	CcSEcCtD
Sparfloxacin—Alopecia—Methotrexate—breast cancer	2.62e-05	0.000174	CcSEcCtD
Sparfloxacin—Vomiting—Gemcitabine—breast cancer	2.62e-05	0.000174	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—TYMS—breast cancer	2.62e-05	0.000474	CbGpPWpGaD
Sparfloxacin—Dyspnoea—Docetaxel—breast cancer	2.61e-05	0.000173	CcSEcCtD
Sparfloxacin—Somnolence—Docetaxel—breast cancer	2.6e-05	0.000172	CcSEcCtD
Sparfloxacin—Rash—Gemcitabine—breast cancer	2.6e-05	0.000172	CcSEcCtD
Sparfloxacin—Dermatitis—Gemcitabine—breast cancer	2.6e-05	0.000172	CcSEcCtD
Sparfloxacin—Tinnitus—Epirubicin—breast cancer	2.59e-05	0.000172	CcSEcCtD
Sparfloxacin—Haemoglobin—Doxorubicin—breast cancer	2.58e-05	0.000171	CcSEcCtD
Sparfloxacin—Headache—Gemcitabine—breast cancer	2.58e-05	0.000171	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Capecitabine—breast cancer	2.58e-05	0.000171	CcSEcCtD
Sparfloxacin—Vomiting—Fluorouracil—breast cancer	2.58e-05	0.000171	CcSEcCtD
Sparfloxacin—Rhinitis—Doxorubicin—breast cancer	2.58e-05	0.000171	CcSEcCtD
Sparfloxacin—Dyspepsia—Docetaxel—breast cancer	2.58e-05	0.000171	CcSEcCtD
Sparfloxacin—Haemorrhage—Doxorubicin—breast cancer	2.57e-05	0.00017	CcSEcCtD
Sparfloxacin—Hepatitis—Doxorubicin—breast cancer	2.57e-05	0.00017	CcSEcCtD
Sparfloxacin—Insomnia—Capecitabine—breast cancer	2.56e-05	0.00017	CcSEcCtD
Sparfloxacin—Hypoaesthesia—Doxorubicin—breast cancer	2.56e-05	0.000169	CcSEcCtD
Sparfloxacin—Rash—Fluorouracil—breast cancer	2.56e-05	0.000169	CcSEcCtD
Sparfloxacin—Dermatitis—Fluorouracil—breast cancer	2.55e-05	0.000169	CcSEcCtD
Sparfloxacin—Pharyngitis—Doxorubicin—breast cancer	2.55e-05	0.000169	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—breast cancer	2.55e-05	0.000462	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PAK1—breast cancer	2.55e-05	0.000462	CbGpPWpGaD
Sparfloxacin—Paraesthesia—Capecitabine—breast cancer	2.54e-05	0.000168	CcSEcCtD
Sparfloxacin—Decreased appetite—Docetaxel—breast cancer	2.54e-05	0.000168	CcSEcCtD
Sparfloxacin—Hypersensitivity—Paclitaxel—breast cancer	2.54e-05	0.000168	CcSEcCtD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC2A5—breast cancer	2.54e-05	0.00046	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLCO1B1—breast cancer	2.54e-05	0.00046	CbGpPWpGaD
Sparfloxacin—Headache—Fluorouracil—breast cancer	2.54e-05	0.000168	CcSEcCtD
Sparfloxacin—Oedema peripheral—Doxorubicin—breast cancer	2.53e-05	0.000168	CcSEcCtD
Sparfloxacin—Dysgeusia—Methotrexate—breast cancer	2.53e-05	0.000168	CcSEcCtD
Sparfloxacin—Dyspnoea—Capecitabine—breast cancer	2.53e-05	0.000167	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—H2AFX—breast cancer	2.52e-05	0.000457	CbGpPWpGaD
Sparfloxacin—Nausea—Mitoxantrone—breast cancer	2.52e-05	0.000166	CcSEcCtD
Sparfloxacin—Nausea—Irinotecan—breast cancer	2.52e-05	0.000166	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	2.51e-05	0.000455	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—E2F1—breast cancer	2.5e-05	0.000453	CbGpPWpGaD
Sparfloxacin—Constipation—Docetaxel—breast cancer	2.5e-05	0.000166	CcSEcCtD
Sparfloxacin—Pain—Docetaxel—breast cancer	2.5e-05	0.000166	CcSEcCtD
Sparfloxacin—Back pain—Methotrexate—breast cancer	2.5e-05	0.000166	CcSEcCtD
Sparfloxacin—Dyspepsia—Capecitabine—breast cancer	2.49e-05	0.000165	CcSEcCtD
Sparfloxacin—Chills—Epirubicin—breast cancer	2.49e-05	0.000165	CcSEcCtD
Sparfloxacin—Arrhythmia—Epirubicin—breast cancer	2.48e-05	0.000164	CcSEcCtD
Sparfloxacin—Asthenia—Paclitaxel—breast cancer	2.48e-05	0.000164	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—breast cancer	2.47e-05	0.000447	CbGpPWpGaD
Sparfloxacin—Decreased appetite—Capecitabine—breast cancer	2.46e-05	0.000163	CcSEcCtD
Sparfloxacin—Alopecia—Epirubicin—breast cancer	2.46e-05	0.000163	CcSEcCtD
Sparfloxacin—Nausea—Gemcitabine—breast cancer	2.45e-05	0.000162	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—TFRC—breast cancer	2.45e-05	0.000443	CbGpPWpGaD
Sparfloxacin—Pruritus—Paclitaxel—breast cancer	2.44e-05	0.000162	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	2.44e-05	0.000442	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—HMOX1—breast cancer	2.44e-05	0.000442	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	2.44e-05	0.000441	CbGpPWpGaD
Sparfloxacin—Erythema multiforme—Doxorubicin—breast cancer	2.43e-05	0.000161	CcSEcCtD
Sparfloxacin—Constipation—Capecitabine—breast cancer	2.42e-05	0.00016	CcSEcCtD
Sparfloxacin—Pain—Capecitabine—breast cancer	2.42e-05	0.00016	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CDK2—breast cancer	2.42e-05	0.000437	CbGpPWpGaD
Sparfloxacin—Feeling abnormal—Docetaxel—breast cancer	2.41e-05	0.00016	CcSEcCtD
Sparfloxacin—Nausea—Fluorouracil—breast cancer	2.41e-05	0.000159	CcSEcCtD
Sparfloxacin—Ill-defined disorder—Methotrexate—breast cancer	2.4e-05	0.000159	CcSEcCtD
Sparfloxacin—Tinnitus—Doxorubicin—breast cancer	2.4e-05	0.000159	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Docetaxel—breast cancer	2.39e-05	0.000158	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	2.39e-05	0.000433	CbGpPWpGaD
Sparfloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—breast cancer	2.39e-05	0.000432	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EGR1—breast cancer	2.39e-05	0.000432	CbGpPWpGaD
Sparfloxacin—Flatulence—Epirubicin—breast cancer	2.38e-05	0.000158	CcSEcCtD
Sparfloxacin—Tension—Epirubicin—breast cancer	2.37e-05	0.000157	CcSEcCtD
Sparfloxacin—Dysgeusia—Epirubicin—breast cancer	2.37e-05	0.000157	CcSEcCtD
Sparfloxacin—Diarrhoea—Paclitaxel—breast cancer	2.36e-05	0.000156	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—BIRC5—breast cancer	2.35e-05	0.000426	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—NCOA2—breast cancer	2.35e-05	0.000426	CbGpPWpGaD
Sparfloxacin—Nervousness—Epirubicin—breast cancer	2.35e-05	0.000156	CcSEcCtD
Sparfloxacin—ABCB1—Allograft Rejection—IFNG—breast cancer	2.35e-05	0.000425	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—ABCB1—breast cancer	2.34e-05	0.000424	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—JUN—breast cancer	2.34e-05	0.000424	CbGpPWpGaD
Sparfloxacin—Back pain—Epirubicin—breast cancer	2.34e-05	0.000155	CcSEcCtD
Sparfloxacin—Feeling abnormal—Capecitabine—breast cancer	2.34e-05	0.000155	CcSEcCtD
Sparfloxacin—Malaise—Methotrexate—breast cancer	2.33e-05	0.000154	CcSEcCtD
Sparfloxacin—Vertigo—Methotrexate—breast cancer	2.32e-05	0.000154	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Capecitabine—breast cancer	2.32e-05	0.000153	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—breast cancer	2.32e-05	0.000419	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—breast cancer	2.32e-05	0.000419	CbGpPWpGaD
Sparfloxacin—Abdominal pain—Docetaxel—breast cancer	2.31e-05	0.000153	CcSEcCtD
Sparfloxacin—Body temperature increased—Docetaxel—breast cancer	2.31e-05	0.000153	CcSEcCtD
Sparfloxacin—Chills—Doxorubicin—breast cancer	2.31e-05	0.000153	CcSEcCtD
Sparfloxacin—Arrhythmia—Doxorubicin—breast cancer	2.3e-05	0.000152	CcSEcCtD
Sparfloxacin—Dizziness—Paclitaxel—breast cancer	2.28e-05	0.000151	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CDK4—breast cancer	2.28e-05	0.000413	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—TERT—breast cancer	2.28e-05	0.000413	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	2.28e-05	0.000412	CbGpPWpGaD
Sparfloxacin—Alopecia—Doxorubicin—breast cancer	2.27e-05	0.00015	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	2.26e-05	0.000409	CbGpPWpGaD
Sparfloxacin—Cough—Methotrexate—breast cancer	2.26e-05	0.000149	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—AR—breast cancer	2.25e-05	0.000408	CbGpPWpGaD
Sparfloxacin—Urticaria—Capecitabine—breast cancer	2.25e-05	0.000149	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SLC5A5—breast cancer	2.25e-05	0.000407	CbGpPWpGaD
Sparfloxacin—Ill-defined disorder—Epirubicin—breast cancer	2.24e-05	0.000149	CcSEcCtD
Sparfloxacin—Abdominal pain—Capecitabine—breast cancer	2.24e-05	0.000148	CcSEcCtD
Sparfloxacin—Body temperature increased—Capecitabine—breast cancer	2.24e-05	0.000148	CcSEcCtD
Sparfloxacin—Convulsion—Methotrexate—breast cancer	2.24e-05	0.000148	CcSEcCtD
Sparfloxacin—Agitation—Epirubicin—breast cancer	2.22e-05	0.000147	CcSEcCtD
Sparfloxacin—Flatulence—Doxorubicin—breast cancer	2.21e-05	0.000146	CcSEcCtD
Sparfloxacin—Myalgia—Methotrexate—breast cancer	2.2e-05	0.000146	CcSEcCtD
Sparfloxacin—Arthralgia—Methotrexate—breast cancer	2.2e-05	0.000146	CcSEcCtD
Sparfloxacin—Chest pain—Methotrexate—breast cancer	2.2e-05	0.000146	CcSEcCtD
Sparfloxacin—Tension—Doxorubicin—breast cancer	2.2e-05	0.000145	CcSEcCtD
Sparfloxacin—Vomiting—Paclitaxel—breast cancer	2.2e-05	0.000145	CcSEcCtD
Sparfloxacin—Dysgeusia—Doxorubicin—breast cancer	2.19e-05	0.000145	CcSEcCtD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC39A6—breast cancer	2.19e-05	0.000396	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—CXCL8—breast cancer	2.18e-05	0.000395	CbGpPWpGaD
Sparfloxacin—Malaise—Epirubicin—breast cancer	2.18e-05	0.000144	CcSEcCtD
Sparfloxacin—Rash—Paclitaxel—breast cancer	2.18e-05	0.000144	CcSEcCtD
Sparfloxacin—Dermatitis—Paclitaxel—breast cancer	2.18e-05	0.000144	CcSEcCtD
Sparfloxacin—Discomfort—Methotrexate—breast cancer	2.17e-05	0.000144	CcSEcCtD
Sparfloxacin—Nervousness—Doxorubicin—breast cancer	2.17e-05	0.000144	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFA—breast cancer	2.17e-05	0.000393	CbGpPWpGaD
Sparfloxacin—Vertigo—Epirubicin—breast cancer	2.17e-05	0.000144	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SLC2A1—breast cancer	2.17e-05	0.000393	CbGpPWpGaD
Sparfloxacin—Back pain—Doxorubicin—breast cancer	2.17e-05	0.000143	CcSEcCtD
Sparfloxacin—Headache—Paclitaxel—breast cancer	2.16e-05	0.000143	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—CDK2—breast cancer	2.16e-05	0.000391	CbGpPWpGaD
Sparfloxacin—Hypersensitivity—Docetaxel—breast cancer	2.16e-05	0.000143	CcSEcCtD
Sparfloxacin—Palpitations—Epirubicin—breast cancer	2.14e-05	0.000142	CcSEcCtD
Sparfloxacin—Confusional state—Methotrexate—breast cancer	2.13e-05	0.000141	CcSEcCtD
Sparfloxacin—ABCC2—NRF2 pathway—TGFB1—breast cancer	2.12e-05	0.000383	CbGpPWpGaD
Sparfloxacin—Cough—Epirubicin—breast cancer	2.11e-05	0.00014	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Methotrexate—breast cancer	2.11e-05	0.00014	CcSEcCtD
Sparfloxacin—Asthenia—Docetaxel—breast cancer	2.1e-05	0.000139	CcSEcCtD
Sparfloxacin—Convulsion—Epirubicin—breast cancer	2.1e-05	0.000139	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—breast cancer	2.09e-05	0.000379	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—STAT5A—breast cancer	2.09e-05	0.000379	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—breast cancer	2.09e-05	0.000379	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—IL1B—breast cancer	2.09e-05	0.000379	CbGpPWpGaD
Sparfloxacin—Hypertension—Epirubicin—breast cancer	2.09e-05	0.000138	CcSEcCtD
Sparfloxacin—ABCB1—Allograft Rejection—CASP3—breast cancer	2.09e-05	0.000378	CbGpPWpGaD
Sparfloxacin—Hypersensitivity—Capecitabine—breast cancer	2.09e-05	0.000138	CcSEcCtD
Sparfloxacin—ABCB1—Allograft Rejection—IL2—breast cancer	2.08e-05	0.000377	CbGpPWpGaD
Sparfloxacin—Ill-defined disorder—Doxorubicin—breast cancer	2.08e-05	0.000137	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	2.07e-05	0.000375	CbGpPWpGaD
Sparfloxacin—Pruritus—Docetaxel—breast cancer	2.07e-05	0.000137	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Methotrexate—breast cancer	2.07e-05	0.000137	CcSEcCtD
Sparfloxacin—Arthralgia—Epirubicin—breast cancer	2.06e-05	0.000136	CcSEcCtD
Sparfloxacin—Myalgia—Epirubicin—breast cancer	2.06e-05	0.000136	CcSEcCtD
Sparfloxacin—Chest pain—Epirubicin—breast cancer	2.06e-05	0.000136	CcSEcCtD
Sparfloxacin—Agitation—Doxorubicin—breast cancer	2.06e-05	0.000136	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—breast cancer	2.05e-05	0.000372	CbGpPWpGaD
Sparfloxacin—Anxiety—Epirubicin—breast cancer	2.05e-05	0.000136	CcSEcCtD
Sparfloxacin—Nausea—Paclitaxel—breast cancer	2.05e-05	0.000136	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—ATM—breast cancer	2.05e-05	0.000371	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—breast cancer	2.05e-05	0.00037	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CDK4—breast cancer	2.04e-05	0.00037	CbGpPWpGaD
Sparfloxacin—Hyperhidrosis—Methotrexate—breast cancer	2.04e-05	0.000135	CcSEcCtD
Sparfloxacin—Discomfort—Epirubicin—breast cancer	2.03e-05	0.000135	CcSEcCtD
Sparfloxacin—Asthenia—Capecitabine—breast cancer	2.03e-05	0.000135	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—breast cancer	2.03e-05	0.000367	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—breast cancer	2.03e-05	0.000367	CbGpPWpGaD
Sparfloxacin—Malaise—Doxorubicin—breast cancer	2.02e-05	0.000134	CcSEcCtD
Sparfloxacin—Dry mouth—Epirubicin—breast cancer	2.01e-05	0.000133	CcSEcCtD
Sparfloxacin—Vertigo—Doxorubicin—breast cancer	2.01e-05	0.000133	CcSEcCtD
Sparfloxacin—Anorexia—Methotrexate—breast cancer	2.01e-05	0.000133	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	2.01e-05	0.000363	CbGpPWpGaD
Sparfloxacin—Pruritus—Capecitabine—breast cancer	2e-05	0.000133	CcSEcCtD
Sparfloxacin—Diarrhoea—Docetaxel—breast cancer	2e-05	0.000133	CcSEcCtD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ATP7B—breast cancer	2e-05	0.000362	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—breast cancer	1.99e-05	0.000361	CbGpPWpGaD
Sparfloxacin—Confusional state—Epirubicin—breast cancer	1.99e-05	0.000132	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—RB1—breast cancer	1.99e-05	0.000359	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—NCOA1—breast cancer	1.98e-05	0.000359	CbGpPWpGaD
Sparfloxacin—Palpitations—Doxorubicin—breast cancer	1.98e-05	0.000131	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Epirubicin—breast cancer	1.97e-05	0.000131	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—breast cancer	1.97e-05	0.000356	CbGpPWpGaD
Sparfloxacin—Cough—Doxorubicin—breast cancer	1.95e-05	0.000129	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—breast cancer	1.95e-05	0.000352	CbGpPWpGaD
Sparfloxacin—Convulsion—Doxorubicin—breast cancer	1.94e-05	0.000128	CcSEcCtD
Sparfloxacin—Diarrhoea—Capecitabine—breast cancer	1.94e-05	0.000128	CcSEcCtD
Sparfloxacin—Dizziness—Docetaxel—breast cancer	1.94e-05	0.000128	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—PLG—breast cancer	1.93e-05	0.00035	CbGpPWpGaD
Sparfloxacin—Thrombocytopenia—Epirubicin—breast cancer	1.93e-05	0.000128	CcSEcCtD
Sparfloxacin—Hypertension—Doxorubicin—breast cancer	1.93e-05	0.000128	CcSEcCtD
Sparfloxacin—Tachycardia—Epirubicin—breast cancer	1.93e-05	0.000128	CcSEcCtD
Sparfloxacin—TOP2A—Circadian rythm related genes—TP53—breast cancer	1.93e-05	0.000349	CbGpPWpGaD
Sparfloxacin—Musculoskeletal discomfort—Methotrexate—breast cancer	1.92e-05	0.000127	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—breast cancer	1.92e-05	0.000347	CbGpPWpGaD
Sparfloxacin—Hyperhidrosis—Epirubicin—breast cancer	1.91e-05	0.000126	CcSEcCtD
Sparfloxacin—Insomnia—Methotrexate—breast cancer	1.91e-05	0.000126	CcSEcCtD
Sparfloxacin—Myalgia—Doxorubicin—breast cancer	1.91e-05	0.000126	CcSEcCtD
Sparfloxacin—Chest pain—Doxorubicin—breast cancer	1.91e-05	0.000126	CcSEcCtD
Sparfloxacin—Arthralgia—Doxorubicin—breast cancer	1.91e-05	0.000126	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—breast cancer	1.91e-05	0.000345	CbGpPWpGaD
Sparfloxacin—Anxiety—Doxorubicin—breast cancer	1.9e-05	0.000126	CcSEcCtD
Sparfloxacin—Paraesthesia—Methotrexate—breast cancer	1.89e-05	0.000125	CcSEcCtD
Sparfloxacin—Discomfort—Doxorubicin—breast cancer	1.88e-05	0.000125	CcSEcCtD
Sparfloxacin—Anorexia—Epirubicin—breast cancer	1.88e-05	0.000125	CcSEcCtD
Sparfloxacin—Dyspnoea—Methotrexate—breast cancer	1.88e-05	0.000125	CcSEcCtD
Sparfloxacin—Somnolence—Methotrexate—breast cancer	1.88e-05	0.000124	CcSEcCtD
Sparfloxacin—Dizziness—Capecitabine—breast cancer	1.87e-05	0.000124	CcSEcCtD
Sparfloxacin—Dry mouth—Doxorubicin—breast cancer	1.86e-05	0.000123	CcSEcCtD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ABCC1—breast cancer	1.86e-05	0.000337	CbGpPWpGaD
Sparfloxacin—Vomiting—Docetaxel—breast cancer	1.86e-05	0.000123	CcSEcCtD
Sparfloxacin—Dyspepsia—Methotrexate—breast cancer	1.86e-05	0.000123	CcSEcCtD
Sparfloxacin—Rash—Docetaxel—breast cancer	1.85e-05	0.000122	CcSEcCtD
Sparfloxacin—Dermatitis—Docetaxel—breast cancer	1.84e-05	0.000122	CcSEcCtD
Sparfloxacin—Confusional state—Doxorubicin—breast cancer	1.84e-05	0.000122	CcSEcCtD
Sparfloxacin—Decreased appetite—Methotrexate—breast cancer	1.83e-05	0.000121	CcSEcCtD
Sparfloxacin—Headache—Docetaxel—breast cancer	1.83e-05	0.000121	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Doxorubicin—breast cancer	1.83e-05	0.000121	CcSEcCtD
Sparfloxacin—Pain—Methotrexate—breast cancer	1.8e-05	0.000119	CcSEcCtD
Sparfloxacin—Vomiting—Capecitabine—breast cancer	1.8e-05	0.000119	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Epirubicin—breast cancer	1.8e-05	0.000119	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Doxorubicin—breast cancer	1.79e-05	0.000118	CcSEcCtD
Sparfloxacin—Rash—Capecitabine—breast cancer	1.79e-05	0.000118	CcSEcCtD
Sparfloxacin—Insomnia—Epirubicin—breast cancer	1.79e-05	0.000118	CcSEcCtD
Sparfloxacin—Dermatitis—Capecitabine—breast cancer	1.79e-05	0.000118	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—HMOX1—breast cancer	1.78e-05	0.000323	CbGpPWpGaD
Sparfloxacin—Tachycardia—Doxorubicin—breast cancer	1.78e-05	0.000118	CcSEcCtD
Sparfloxacin—Headache—Capecitabine—breast cancer	1.78e-05	0.000118	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—RB1—breast cancer	1.78e-05	0.000321	CbGpPWpGaD
Sparfloxacin—Paraesthesia—Epirubicin—breast cancer	1.77e-05	0.000117	CcSEcCtD
Sparfloxacin—ABCB1—Allograft Rejection—VEGFA—breast cancer	1.77e-05	0.000321	CbGpPWpGaD
Sparfloxacin—Hyperhidrosis—Doxorubicin—breast cancer	1.77e-05	0.000117	CcSEcCtD
Sparfloxacin—TOP2A—Circadian rythm related genes—IL6—breast cancer	1.76e-05	0.000319	CbGpPWpGaD
Sparfloxacin—Dyspnoea—Epirubicin—breast cancer	1.76e-05	0.000117	CcSEcCtD
Sparfloxacin—Somnolence—Epirubicin—breast cancer	1.76e-05	0.000116	CcSEcCtD
Sparfloxacin—Anorexia—Doxorubicin—breast cancer	1.74e-05	0.000115	CcSEcCtD
Sparfloxacin—Nausea—Docetaxel—breast cancer	1.74e-05	0.000115	CcSEcCtD
Sparfloxacin—Feeling abnormal—Methotrexate—breast cancer	1.74e-05	0.000115	CcSEcCtD
Sparfloxacin—Dyspepsia—Epirubicin—breast cancer	1.74e-05	0.000115	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Methotrexate—breast cancer	1.73e-05	0.000114	CcSEcCtD
Sparfloxacin—Decreased appetite—Epirubicin—breast cancer	1.72e-05	0.000114	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—ABCB1—breast cancer	1.71e-05	0.00031	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	1.69e-05	0.000307	CbGpPWpGaD
Sparfloxacin—Pain—Epirubicin—breast cancer	1.69e-05	0.000112	CcSEcCtD
Sparfloxacin—Constipation—Epirubicin—breast cancer	1.69e-05	0.000112	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—breast cancer	1.68e-05	0.000305	CbGpPWpGaD
Sparfloxacin—Nausea—Capecitabine—breast cancer	1.68e-05	0.000111	CcSEcCtD
Sparfloxacin—Urticaria—Methotrexate—breast cancer	1.68e-05	0.000111	CcSEcCtD
Sparfloxacin—Abdominal pain—Methotrexate—breast cancer	1.67e-05	0.00011	CcSEcCtD
Sparfloxacin—Body temperature increased—Methotrexate—breast cancer	1.67e-05	0.00011	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.66e-05	0.00011	CcSEcCtD
Sparfloxacin—Insomnia—Doxorubicin—breast cancer	1.65e-05	0.000109	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—breast cancer	1.64e-05	0.000297	CbGpPWpGaD
Sparfloxacin—Paraesthesia—Doxorubicin—breast cancer	1.64e-05	0.000109	CcSEcCtD
Sparfloxacin—ABCB1—Metabolism—SYNJ2—breast cancer	1.63e-05	0.000296	CbGpPWpGaD
Sparfloxacin—Dyspnoea—Doxorubicin—breast cancer	1.63e-05	0.000108	CcSEcCtD
Sparfloxacin—Feeling abnormal—Epirubicin—breast cancer	1.63e-05	0.000108	CcSEcCtD
Sparfloxacin—ABCB1—Allograft Rejection—TGFB1—breast cancer	1.63e-05	0.000294	CbGpPWpGaD
Sparfloxacin—Somnolence—Doxorubicin—breast cancer	1.62e-05	0.000108	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Epirubicin—breast cancer	1.61e-05	0.000107	CcSEcCtD
Sparfloxacin—Dyspepsia—Doxorubicin—breast cancer	1.61e-05	0.000106	CcSEcCtD
Sparfloxacin—Decreased appetite—Doxorubicin—breast cancer	1.59e-05	0.000105	CcSEcCtD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—TUBB3—breast cancer	1.58e-05	0.000287	CbGpPWpGaD
Sparfloxacin—Urticaria—Epirubicin—breast cancer	1.57e-05	0.000104	CcSEcCtD
Sparfloxacin—Constipation—Doxorubicin—breast cancer	1.56e-05	0.000103	CcSEcCtD
Sparfloxacin—Pain—Doxorubicin—breast cancer	1.56e-05	0.000103	CcSEcCtD
Sparfloxacin—Body temperature increased—Epirubicin—breast cancer	1.56e-05	0.000103	CcSEcCtD
Sparfloxacin—Abdominal pain—Epirubicin—breast cancer	1.56e-05	0.000103	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—breast cancer	1.56e-05	0.000282	CbGpPWpGaD
Sparfloxacin—Hypersensitivity—Methotrexate—breast cancer	1.55e-05	0.000103	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—breast cancer	1.55e-05	0.000281	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—breast cancer	1.55e-05	0.00028	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—breast cancer	1.55e-05	0.00028	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—TNF—breast cancer	1.52e-05	0.000275	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—NDUFS3—breast cancer	1.52e-05	0.000275	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—MDM2—breast cancer	1.51e-05	0.000274	CbGpPWpGaD
Sparfloxacin—Asthenia—Methotrexate—breast cancer	1.51e-05	0.0001	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—breast cancer	1.51e-05	0.000273	CbGpPWpGaD
Sparfloxacin—Feeling abnormal—Doxorubicin—breast cancer	1.51e-05	9.96e-05	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Doxorubicin—breast cancer	1.49e-05	9.89e-05	CcSEcCtD
Sparfloxacin—Pruritus—Methotrexate—breast cancer	1.49e-05	9.88e-05	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—breast cancer	1.47e-05	0.000267	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—ALB—breast cancer	1.47e-05	0.000265	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—breast cancer	1.46e-05	0.000265	CbGpPWpGaD
Sparfloxacin—Hypersensitivity—Epirubicin—breast cancer	1.45e-05	9.63e-05	CcSEcCtD
Sparfloxacin—Urticaria—Doxorubicin—breast cancer	1.45e-05	9.61e-05	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—breast cancer	1.45e-05	0.000262	CbGpPWpGaD
Sparfloxacin—Body temperature increased—Doxorubicin—breast cancer	1.44e-05	9.56e-05	CcSEcCtD
Sparfloxacin—Abdominal pain—Doxorubicin—breast cancer	1.44e-05	9.56e-05	CcSEcCtD
Sparfloxacin—Diarrhoea—Methotrexate—breast cancer	1.44e-05	9.55e-05	CcSEcCtD
Sparfloxacin—ABCB1—Metabolism—CHST9—breast cancer	1.43e-05	0.000258	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1A—breast cancer	1.43e-05	0.000258	CbGpPWpGaD
Sparfloxacin—Asthenia—Epirubicin—breast cancer	1.42e-05	9.38e-05	CcSEcCtD
Sparfloxacin—Pruritus—Epirubicin—breast cancer	1.4e-05	9.25e-05	CcSEcCtD
Sparfloxacin—Dizziness—Methotrexate—breast cancer	1.4e-05	9.23e-05	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—CDKN1B—breast cancer	1.38e-05	0.00025	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—breast cancer	1.36e-05	0.000246	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—COX11—breast cancer	1.35e-05	0.000245	CbGpPWpGaD
Sparfloxacin—Diarrhoea—Epirubicin—breast cancer	1.35e-05	8.94e-05	CcSEcCtD
Sparfloxacin—Hypersensitivity—Doxorubicin—breast cancer	1.35e-05	8.91e-05	CcSEcCtD
Sparfloxacin—Vomiting—Methotrexate—breast cancer	1.34e-05	8.88e-05	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—breast cancer	1.34e-05	0.000242	CbGpPWpGaD
Sparfloxacin—Rash—Methotrexate—breast cancer	1.33e-05	8.81e-05	CcSEcCtD
Sparfloxacin—Dermatitis—Methotrexate—breast cancer	1.33e-05	8.8e-05	CcSEcCtD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—RAF1—breast cancer	1.33e-05	0.00024	CbGpPWpGaD
Sparfloxacin—Headache—Methotrexate—breast cancer	1.32e-05	8.75e-05	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—CCND1—breast cancer	1.32e-05	0.000239	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC2A2—breast cancer	1.32e-05	0.000238	CbGpPWpGaD
Sparfloxacin—Asthenia—Doxorubicin—breast cancer	1.31e-05	8.68e-05	CcSEcCtD
Sparfloxacin—Dizziness—Epirubicin—breast cancer	1.31e-05	8.64e-05	CcSEcCtD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—AKT1—breast cancer	1.31e-05	0.000236	CbGpPWpGaD
Sparfloxacin—Pruritus—Doxorubicin—breast cancer	1.29e-05	8.56e-05	CcSEcCtD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ABCG2—breast cancer	1.29e-05	0.000234	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CDKN1A—breast cancer	1.28e-05	0.000231	CbGpPWpGaD
Sparfloxacin—Vomiting—Epirubicin—breast cancer	1.26e-05	8.31e-05	CcSEcCtD
Sparfloxacin—Nausea—Methotrexate—breast cancer	1.25e-05	8.29e-05	CcSEcCtD
Sparfloxacin—Diarrhoea—Doxorubicin—breast cancer	1.25e-05	8.27e-05	CcSEcCtD
Sparfloxacin—Rash—Epirubicin—breast cancer	1.24e-05	8.24e-05	CcSEcCtD
Sparfloxacin—Dermatitis—Epirubicin—breast cancer	1.24e-05	8.23e-05	CcSEcCtD
Sparfloxacin—ABCB1—Metabolism—CDA—breast cancer	1.24e-05	0.000224	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SHMT1—breast cancer	1.24e-05	0.000224	CbGpPWpGaD
Sparfloxacin—Headache—Epirubicin—breast cancer	1.24e-05	8.19e-05	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—breast cancer	1.22e-05	0.00022	CbGpPWpGaD
Sparfloxacin—Dizziness—Doxorubicin—breast cancer	1.21e-05	8e-05	CcSEcCtD
Sparfloxacin—ABCB1—Metabolism—SLCO1B1—breast cancer	1.19e-05	0.000216	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SLC2A5—breast cancer	1.19e-05	0.000216	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—MYC—breast cancer	1.18e-05	0.000214	CbGpPWpGaD
Sparfloxacin—Nausea—Epirubicin—breast cancer	1.17e-05	7.76e-05	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—breast cancer	1.17e-05	0.000212	CbGpPWpGaD
Sparfloxacin—Vomiting—Doxorubicin—breast cancer	1.16e-05	7.69e-05	CcSEcCtD
Sparfloxacin—Rash—Doxorubicin—breast cancer	1.15e-05	7.62e-05	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—breast cancer	1.15e-05	0.000208	CbGpPWpGaD
Sparfloxacin—Dermatitis—Doxorubicin—breast cancer	1.15e-05	7.62e-05	CcSEcCtD
Sparfloxacin—ABCB1—Metabolism—APRT—breast cancer	1.15e-05	0.000208	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—TFRC—breast cancer	1.15e-05	0.000208	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—breast cancer	1.15e-05	0.000208	CbGpPWpGaD
Sparfloxacin—Headache—Doxorubicin—breast cancer	1.14e-05	7.58e-05	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—breast cancer	1.14e-05	0.000205	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—breast cancer	1.11e-05	0.000201	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—NCOA2—breast cancer	1.11e-05	0.0002	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—MAPK3—breast cancer	1.09e-05	0.000197	CbGpPWpGaD
Sparfloxacin—Nausea—Doxorubicin—breast cancer	1.09e-05	7.18e-05	CcSEcCtD
Sparfloxacin—ABCB1—Metabolism—ANGPTL4—breast cancer	1.08e-05	0.000196	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ESRRA—breast cancer	1.08e-05	0.000196	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—ALB—breast cancer	1.07e-05	0.000194	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—MYC—breast cancer	1.06e-05	0.000191	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC5A5—breast cancer	1.06e-05	0.000191	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—breast cancer	1.05e-05	0.00019	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—breast cancer	1.03e-05	0.000187	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—HADHB—breast cancer	1.03e-05	0.000186	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GPI—breast cancer	1.03e-05	0.000186	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC2A1—breast cancer	1.02e-05	0.000185	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—breast cancer	1e-05	0.000182	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—breast cancer	1e-05	0.000181	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—breast cancer	9.93e-06	0.00018	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ALDH7A1—breast cancer	9.78e-06	0.000177	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ALDH1A1—breast cancer	9.78e-06	0.000177	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—breast cancer	9.7e-06	0.000176	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—RAF1—breast cancer	9.69e-06	0.000175	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—breast cancer	9.68e-06	0.000175	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—breast cancer	9.47e-06	0.000171	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—NME1—breast cancer	9.38e-06	0.00017	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—FHL2—breast cancer	9.38e-06	0.00017	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PHGDH—breast cancer	9.38e-06	0.00017	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ADSL—breast cancer	9.38e-06	0.00017	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—UMPS—breast cancer	9.38e-06	0.00017	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—NCOA1—breast cancer	9.33e-06	0.000169	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—LDHB—breast cancer	9.2e-06	0.000166	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—HPSE—breast cancer	9.2e-06	0.000166	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—BRIP1—breast cancer	9.2e-06	0.000166	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—PLG—breast cancer	9.09e-06	0.000165	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—breast cancer	8.98e-06	0.000162	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—breast cancer	8.74e-06	0.000158	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ABCC1—breast cancer	8.72e-06	0.000158	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—HMMR—breast cancer	8.72e-06	0.000158	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTA3—breast cancer	8.72e-06	0.000158	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—TP53—breast cancer	8.68e-06	0.000157	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PPARGC1B—breast cancer	8.44e-06	0.000153	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—HMOX1—breast cancer	8.39e-06	0.000152	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	8.27e-06	0.00015	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	8.04e-06	0.000146	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	8.03e-06	0.000145	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTA4—breast cancer	7.97e-06	0.000144	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CA9—breast cancer	7.97e-06	0.000144	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	7.87e-06	0.000142	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTA2—breast cancer	7.77e-06	0.000141	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GPX2—breast cancer	7.77e-06	0.000141	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GPX4—breast cancer	7.68e-06	0.000139	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SULT1A1—breast cancer	7.68e-06	0.000139	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—IDH1—breast cancer	7.5e-06	0.000136	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTA1—breast cancer	7.5e-06	0.000136	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	7.49e-06	0.000136	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	7.43e-06	0.000135	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—NAT2—breast cancer	7.41e-06	0.000134	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	6.83e-06	0.000124	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	6.61e-06	0.00012	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—MED12—breast cancer	6.5e-06	0.000118	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—DPYD—breast cancer	6.5e-06	0.000118	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ALDOA—breast cancer	6.4e-06	0.000116	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—NCOA3—breast cancer	6.21e-06	0.000112	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SLC2A2—breast cancer	6.17e-06	0.000112	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ABCG2—breast cancer	6.04e-06	0.000109	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CPT1A—breast cancer	6.04e-06	0.000109	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—MTR—breast cancer	6.04e-06	0.000109	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—HPGDS—breast cancer	5.93e-06	0.000107	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—HBA1—breast cancer	5.89e-06	0.000107	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTT1—breast cancer	5.75e-06	0.000104	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ACHE—breast cancer	5.75e-06	0.000104	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	5.58e-06	0.000101	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CYP17A1—breast cancer	5.44e-06	9.85e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ENO1—breast cancer	5.39e-06	9.75e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PTGS1—breast cancer	5.39e-06	9.75e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CYP2D6—breast cancer	5.28e-06	9.56e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—NCOA2—breast cancer	5.19e-06	9.39e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	5.04e-06	9.12e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—FASN—breast cancer	5.03e-06	9.1e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—BCHE—breast cancer	5.01e-06	9.06e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SLC5A5—breast cancer	4.95e-06	8.95e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—NQO1—breast cancer	4.78e-06	8.65e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SLC2A1—breast cancer	4.78e-06	8.65e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CYP3A4—breast cancer	4.66e-06	8.43e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CYP1B1—breast cancer	4.58e-06	8.29e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	4.56e-06	8.25e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—HSP90AA1—breast cancer	4.49e-06	8.13e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—NCOA1—breast cancer	4.37e-06	7.91e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CYP19A1—breast cancer	4.31e-06	7.79e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—STK11—breast cancer	4.31e-06	7.79e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—COMT—breast cancer	4e-06	7.25e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTP1—breast cancer	3.98e-06	7.21e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—HMOX1—breast cancer	3.93e-06	7.11e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ITPR1—breast cancer	3.92e-06	7.1e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—TYMS—breast cancer	3.7e-06	6.71e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTM1—breast cancer	3.66e-06	6.63e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PLA2G4A—breast cancer	3.66e-06	6.63e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—NCOR1—breast cancer	3.66e-06	6.63e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GPX1—breast cancer	3.51e-06	6.35e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CYP1A1—breast cancer	3.47e-06	6.28e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ERCC2—breast cancer	3.44e-06	6.23e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—MTHFR—breast cancer	3.24e-06	5.86e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CAV1—breast cancer	2.98e-06	5.4e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PIK3CG—breast cancer	2.72e-06	4.92e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PIK3CD—breast cancer	2.39e-06	4.33e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ALB—breast cancer	2.36e-06	4.27e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—NOS3—breast cancer	2.26e-06	4.09e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PIK3CB—breast cancer	2.08e-06	3.77e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PTGS2—breast cancer	2.06e-06	3.74e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PTEN—breast cancer	1.8e-06	3.26e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PIK3CA—breast cancer	1.27e-06	2.3e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—AKT1—breast cancer	1.04e-06	1.88e-05	CbGpPWpGaD
